Vir Biotechnology refiles prospectus supplement to add omitted exhibitNov 16FinancingVir Biotechnology, Inc.Updated
Vir Biotechnology launches public stock offering following ECLIPSE 1 Phase 3 resultsNov 12Clinical readoutVir Biotechnology, Inc.Updated
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Vir Biotechnology signs TCE collaboration and license deal with Gilead SciencesOct 14FinancingGilead SciencesVir Biotechnology, Inc.
Vir Biotechnology says FDA grants Fast Track to VIR-5500 for prostate cancerOct 8Regulatory milestoneAstellas PharmaVir Biotechnology, Inc.
Vir Biotechnology names Aziz Sawaf as new CFO effective October 5, 2026Oct 1PeopleVir Biotechnology, Inc.
Vir reports Week 96 SOLSTICE data, ECLIPSE program fully enrolled, VIR-5500 expansion underwayAug 5Quarterly updateVir Biotechnology, Inc.VIR-5500
Vir Biotechnology CFO Jason O'Byrne to depart; interim replacement namedJul 24PeopleVir Biotechnology, Inc.
Brii Biosciences posts Phase 2 results for BRII-835/BRII-179 hepatitis B combo trialJul 23Trial updateelebsiranVir Biotechnology, Inc.